SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 20.50+0.1%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: somethingwicked who wrote (276)8/15/2001 6:49:36 AM
From: Dorine Essey  Read Replies (1) of 340
 
I hope you have been holding your TEVA?

Teva ((TEVA.O)) Launches $300 Mln 20-yr Convertible

August 15, 2001 06:35:14 (ET)

JERUSALEM, Aug 15 (Reuters) - Israeli generic drug maker Teva Pharmaceutical Industries said on Wednesday its unit, Teva Pharmaceutical Finance N.V., launched its offering of $300 million of 0.75 percent 20-year convertible senior notes.

The notes will be convertible into Teva's American Depositary Receipts (ADRs) at a conversion price of $85.824 per ADR, reflecting a premium of 28 percent from Tuesday's closing share price of $67.05.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext